Clinical Trials Browser

Completed × NSCLC × Pemetrexed × Clear all

NCT03562871 2022-04-21

IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC

Phase 1/2 Completed

NSCLC

NCT01769066 2016-02-23

Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC

Phase 2/3 Completed

NSCLC